About this trial
Evaluate the outcomes of the patients and their possible predictors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
1. Adult patients aged 18 years or older. 2. Patients fulfilling at least two diagnostic criteria of acute pancreatitis. 3. Patients willing to participate in the study.
Disqualifiers
Patients with chronic pancreatitis.
Patients diagnosed with pancreatic malignancy.
Patients less than 18 years old.
Patients with incomplete clinical data.
Trial population
All enrolled patients will undergo: * Detailed medical history taking including demographic data, comorbidities, smoking, alcohol intake, and possible etiological factors. * Complete clinical examination. * Laboratory investigations including CBC, liver function tests, kidney function tests, serum amylase, serum lipase, calcium profile, lipid profile, and CRP. * Radiological investigations including abdominal ultrasonography and CT abdomen when indicated. * Assessment of severity using Ranson score, APACHE II score and Revised Atlanta classification. * Follow-up during admission for complications, ICU admission, length of hospital stay, and mortality.
Trial design
Cohort
Prospective
Treatments tested in this trial
US,MSCT abdomen,arterial blood gases
Other interventionarterial blood gases
Treatment groups
Trial outcomes
Primary outcomes
Frequency and types of clinical patterns of acute pancreatitis and the fates of patients.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: